Accuray stockholders approve Series A preferred conversion and warrant exercise; board adds director
On October 6, 2026, Accuray stockholders voted to approve the issuance of common stock upon conversion of Series A convertible preferred stock and exercise of warrants at potentially below-market prices under Nasdaq Rule 5635, which may constitute a change of control and involves equity dilution to existing shareholders. The approval clears the path for a financing transaction with existing investors, but at conversion prices below the minimum Nasdaq threshold, signaling financial pressure and significant shareholder dilution.
Accuray got shareholder approval to issue new stock cheap to current investors through preferred shares that convert to common stock. This dilutes existing shareholders but lets the company raise capital.
Information only. AURA does not give buy or sell recommendations.